Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
Technology
E-136-2018
Patent ID
E-136-2018-0-US-01
Country
US
Application Type
Patent Status
Abandoned
Patent Number
Publication Number
Application Number
62/295,421
IC
NCI
Date Filed
Date Issued
Patent PDF